CAPRICOR THERAPEUTICS ($CAPR) posted quarterly earnings results for Q2 2026 on Thursday, August 13th. The company reported earnings of -$0.70 per share, missing estimates of -$0.60 by $0.10. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $CAPR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CAPRICOR THERAPEUTICS Insider Trading Activity
CAPRICOR THERAPEUTICS insiders have traded $CAPR stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CAPR stock by insiders over the last 6 months:
- KARIMAH ES SABAR has made 0 purchases and 3 sales selling 122,529 shares for an estimated $3,756,395.
- ANTHONY BERGMANN (CHIEF FINANCIAL OFFICER) has made 0 purchases and 5 sales selling 75,000 shares for an estimated $2,304,850.
- KAREN KRASNEY (EVP, GENERAL COUNSEL) has made 0 purchases and 5 sales selling 75,000 shares for an estimated $2,304,640.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CAPRICOR THERAPEUTICS Hedge Fund Activity
We have seen 102 institutional investors add shares of CAPRICOR THERAPEUTICS stock to their portfolio, and 74 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUVRETTA CAPITAL MANAGEMENT, LLC added 2,032,990 shares (+113.9%) to their portfolio in Q1 2026, for an estimated $61,802,896
- STATE STREET CORP added 1,215,249 shares (+55.7%) to their portfolio in Q2 2026, for an estimated $29,263,195
- POINT72 ASSET MANAGEMENT, L.P. removed 1,018,697 shares (-55.4%) from their portfolio in Q1 2026, for an estimated $30,968,388
- DARWIN GLOBAL MANAGEMENT, LTD. removed 800,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $24,320,000
- SOLEUS CAPITAL MANAGEMENT, L.P. added 761,737 shares (+inf%) to their portfolio in Q2 2026, for an estimated $18,342,626
- BLACKROCK, INC. added 723,246 shares (+21.1%) to their portfolio in Q2 2026, for an estimated $17,415,763
- JANE STREET GROUP, LLC added 566,081 shares (+inf%) to their portfolio in Q1 2026, for an estimated $17,208,862
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CAPRICOR THERAPEUTICS Price Targets
Multiple analysts have issued price targets for $CAPR recently. We have seen 3 analysts offer price targets for $CAPR in the last 6 months, with a median target of $60.0.
Here are some recent targets:
- Joseph Pantginis from HC Wainwright & Co. set a target price of $60.0 on 05/13/2026
- Madison El-Saadi from B. Riley Securities set a target price of $63.0 on 03/13/2026
- Edward Tenthoff from Piper Sandler set a target price of $58.0 on 03/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
